Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Update on fenoldopam regulatory submission

May 24, 1996

Progress on endothelin antagonists at Texas Biotechnology

May 24, 1996

More angiotensin II antagonists from Japanese companies

May 24, 1996

ADIR claims compounds for venous insufficiency

May 24, 1996

ADIR claims imidazoline I1 receptor ligands for hypertension

May 24, 1996

Baxter will develop graft system developed by Australian investigators

May 24, 1996

Lilly reports agents for septic shock

May 17, 1996

Fujisawa isolates cGMP PDE inhibitor from Pseudomonas

May 17, 1996

Merck & Co. claims class III antiarrhythmics

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...